Clinical End Points and Response Criteria in Mycosis Fungoides and Sézary Syndrome: A Consensus Statement of the International Society for Cutaneous Lymphomas, the United States Cutaneous Lymphoma Consortium, and the Cutaneous Lymphoma Task Force of the European Organisation for Research and Treatment of CancerElise A. Olsen, Eric C. Vonderheid, Sean Whittaker et al.|Journal of Clinical Oncology|2011Cited by 657
Cutaneous Lymphoma International Consortium Study of Outcome in Advanced Stages of Mycosis Fungoides and Sézary Syndrome: Effect of Specific Prognostic Markers on Survival and Development of a Prognostic ModelJulia Scarisbrick, Henry K. Wong, Francine M. Foss et al.|Journal of Clinical Oncology|2015Cited by 419
Genomic landscape of cutaneous T cell lymphomaJaehyuk Choi, Richard P. Lifton, Gerald Goh et al.|Nature Genetics|2015Cited by 418
Primary cutaneous lymphoma: recommendations for clinical trial design and staging update from the ISCL, USCLC, and EORTCElise A. Olsen, Julia Scarisbrick, Sean Whittaker et al.|Blood|2021Cited by 170
Generation and optimization of off-the-shelf immunotherapeutics targeting TCR-Vβ2+ T cell malignancyJingjing Ren, Michael Girardi|Nature Communications|2024Cited by 20